Javier El‐Bietar

1.9k total citations
44 papers, 1.3k citations indexed

About

Javier El‐Bietar is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Javier El‐Bietar has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Immunology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Javier El‐Bietar's work include Hematopoietic Stem Cell Transplantation (16 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Javier El‐Bietar is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Javier El‐Bietar collaborates with scholars based in United States, United Kingdom and Israel. Javier El‐Bietar's co-authors include Christopher E. Dandoy, Kasiani C. Myers, Sonata Jodele, Stella M. Davies, Benjamin L. Laskin, Gregory Wallace, Jens Goebel, Adam Lane, Michael Grimley and Bradley P. Dixon and has published in prestigious journals such as Blood, European Respiratory Journal and Transplantation.

In The Last Decade

Javier El‐Bietar

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier El‐Bietar United States 18 634 472 401 265 162 44 1.3k
Rafael Villicana United States 17 506 0.8× 204 0.4× 1.2k 3.0× 438 1.7× 33 0.2× 22 1.7k
Yaşar Çalışkan Türkiye 20 198 0.3× 105 0.2× 288 0.7× 530 2.0× 82 0.5× 129 1.3k
Enrico Minetti Italy 14 327 0.5× 102 0.2× 281 0.7× 301 1.1× 41 0.3× 35 851
Yoshihiko Watarai Japan 21 277 0.4× 88 0.2× 799 2.0× 401 1.5× 147 0.9× 141 1.6k
Douglas A. Hale United States 23 733 1.2× 176 0.4× 1.1k 2.7× 127 0.5× 70 0.4× 53 2.3k
Nina Tolkoff‐Rubin United States 18 287 0.5× 155 0.3× 613 1.5× 208 0.8× 41 0.3× 29 1.2k
Christopher J. Patriquin Canada 13 600 0.9× 303 0.6× 89 0.2× 348 1.3× 38 0.2× 61 958
Joseph Kahwaji United States 20 544 0.9× 193 0.4× 1.3k 3.3× 432 1.6× 29 0.2× 43 1.8k
G. Mogilishetty United States 15 340 0.5× 145 0.3× 918 2.3× 275 1.0× 33 0.2× 30 1.3k
M. Messina Italy 18 71 0.1× 214 0.5× 347 0.9× 190 0.7× 43 0.3× 55 850

Countries citing papers authored by Javier El‐Bietar

Since Specialization
Citations

This map shows the geographic impact of Javier El‐Bietar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier El‐Bietar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier El‐Bietar more than expected).

Fields of papers citing papers by Javier El‐Bietar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier El‐Bietar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier El‐Bietar. The network helps show where Javier El‐Bietar may publish in the future.

Co-authorship network of co-authors of Javier El‐Bietar

This figure shows the co-authorship network connecting the top 25 collaborators of Javier El‐Bietar. A scholar is included among the top collaborators of Javier El‐Bietar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier El‐Bietar. Javier El‐Bietar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khandelwal, Pooja, Tsuyoshi Fukuda, Ashley Teusink‐Cross, et al.. (2020). CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study. Bone Marrow Transplantation. 55(8). 1552–1559. 7 indexed citations
2.
Rotz, Seth J., Adam W. Powell, Kasiani C. Myers, et al.. (2019). Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation. Cardiology in the Young. 29(3). 338–343. 3 indexed citations
3.
Andersen, Heidi, David Haslam, Adam Nelson, et al.. (2019). Modulation of the Oral Microbiome to Improve Oral Health and Reduce BSI from Oral Flora in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Randomized Controlled Trial. Biology of Blood and Marrow Transplantation. 25(3). S88–S89. 2 indexed citations
4.
Walkup, Laura L., Kasiani C. Myers, Javier El‐Bietar, et al.. (2018). Regional Lung Ventilation Deficits in Pediatric Hematopoietic Stem Cell Transplant Patients Revealed via Hyperpolarized Xenon-129 Magnetic Resonance Imaging. Biology of Blood and Marrow Transplantation. 24(3). S66–S66. 2 indexed citations
5.
Wallace, Gregory, Sonata Jodele, Kasiani C. Myers, et al.. (2018). Single Ultra-High-Dose Cholecalciferol to Prevent Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(9). 1856–1860. 22 indexed citations
6.
Warren, Mikako, Sonata Jodele, Christopher E. Dandoy, et al.. (2017). A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy. Archives of Pathology & Laboratory Medicine. 141(11). 1558–1566. 28 indexed citations
7.
Rotz, Seth J., Thomas D. Ryan, Sonata Jodele, et al.. (2017). The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults. Bone Marrow Transplantation. 52(8). 1171–1179. 17 indexed citations
8.
Teusink‐Cross, Ashley, Stella M. Davies, Lara Danziger‐Isakov, Javier El‐Bietar, & Michael Grimley. (2016). Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients. Biology of Blood and Marrow Transplantation. 22(10). 1904–1906. 9 indexed citations
9.
Wallace, Gregory, Sonata Jodele, Kasiani C. Myers, et al.. (2016). Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation Patients Despite Both Standard and Aggressive Supplementation. Biology of Blood and Marrow Transplantation. 22(7). 1271–1274. 24 indexed citations
10.
Myers, Kasiani C., J. Christina Howell, Gregory L. Wallace, et al.. (2016). Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults. Bone Marrow Transplantation. 51(7). 980–984. 21 indexed citations
11.
Khandelwal, Pooja, Chie Emoto, Tsuyoshi Fukuda, et al.. (2016). A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(12). 2220–2225. 18 indexed citations
12.
Dandoy, Christopher E., Luke L. Linscott, Stella M. Davies, et al.. (2015). Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents. Biology of Blood and Marrow Transplantation. 21(11). 2028–2032. 27 indexed citations
13.
Jodele, Sonata, Benjamin L. Laskin, Tsuyoshi Fukuda, et al.. (2015). Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA). Biology of Blood and Marrow Transplantation. 21(2). S225–S226. 2 indexed citations
14.
El‐Bietar, Javier, Mikako Warren, Christopher E. Dandoy, et al.. (2015). Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(11). 1994–2001. 54 indexed citations
16.
Myers, Kasiani C., Christopher E. Dandoy, Javier El‐Bietar, Stella M. Davies, & Sonata Jodele. (2014). Veno-Occlusive Disease of the Liver in the Absence of Elevation in Bilirubin in Pediatric Patients after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(2). 379–381. 29 indexed citations
17.
Dandoy, Christopher E., Stella M. Davies, Russel Hirsch, et al.. (2014). Abnormal Echocardiography 7 Days after Stem Cell Transplantation May Be an Early Indicator of Thrombotic Microangiopathy. Biology of Blood and Marrow Transplantation. 21(1). 113–118. 35 indexed citations
18.
El‐Bietar, Javier, Caridad Martinez, Catherine M. Bollard, et al.. (2013). Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT). Biology of Blood and Marrow Transplantation. 19(2). S195–S196.
19.
Dvorak, Christopher C., Catherine M. Bollard, Javier El‐Bietar, & Alexandra H. Filipovich. (2012). Complications of Transplant for Nonmalignant Disorders: Autoimmune Cytopenias, Opportunistic Infections, and PTLD. Biology of Blood and Marrow Transplantation. 18(1). S101–S110. 5 indexed citations
20.
El‐Bietar, Javier & Catherine M. Bollard. (2011). T-Cell Therapies for Epstein-Barr Virus–Associated Lymphomas. Pediatric Hematology and Oncology. 28(8). 627–639. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026